Literature DB >> 23498381

Alternative decision-makers' perspectives on assent and dissent for dementia research.

Eve Overton1, Paul S Appelbaum, Stephanie Reyes Fisher, Daniel Dohan, Laura Weiss Roberts, Laura B Dunn.   

Abstract

OBJECTIVES: Investigators generally address the ethical dilemma of patients' decisional impairment in Alzheimer disease (AD) research by obtaining consent from alternative or surrogate decision makers ("proxies") as well as assent from patients. How these proxies conceptualize patient assent, or lack of objection, to participate may influence decisions made of the patients' behalf, but has been little studied. This report examines statements of proxies relevant to how they conceptualized assent and dissent to research.
DESIGN: Surveys and in-depth interviews of proxies presented with hypothetical scenario related to enrolling relatives with AD in a clinical trial of an investigational drug for AD. PARTICIPANTS: Proxies (n = 25) for people with AD. MEASUREMENTS: Open-ended and rating-scaled items assessing perspectives on enrollment in research, influences on decision-making, and willingness to override a relative's preferences regarding research participation. Statements with relevance to assent or dissent were coded.
RESULTS: Proxies described looking for consistent behavioral or verbal indications of assent versus objection when trying to determine patients' preferences. However, proxies sometimes expressed willingness to override patients' desires in favor of patients' presumed best interests. The amnestic nature of the disorder led some proxies to justify overriding temporary dissent or discomfort in the interest of promoting patients' values. Patients' dependence on their caregivers for decision-making, and caregivers' awareness of their ability to persuade their relatives, also emerged in descriptions of the decision-making process.
CONCLUSIONS: Proxies' statements regarding a hypothetical research enrollment decision revealed several themes with implications for the concepts of assent and dissent. Proxies may persuade or influence patients to promote the patient's best interests or values. Further work, particularly examining actual decision-making, is warranted to determine how best to operationalize the concepts of assent and dissent in the context of research involving decisionally impaired adults.
Copyright © 2013 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23498381     DOI: 10.1016/j.jagp.2013.01.027

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  9 in total

1.  Attitudes of Mothers Regarding Willingness to Enroll Their Children in Research.

Authors:  Jane Paik Kim; Maryam Rostami; Laura Weiss Roberts
Journal:  J Empir Res Hum Res Ethics       Date:  2020-06-18       Impact factor: 1.742

2.  Do human subject safeguards matter to potential participants in psychiatric genetic research?

Authors:  Laura Weiss Roberts; Jane Paik Kim; Tenzin Tsungmey; Laura B Dunn
Journal:  J Psychiatr Res       Date:  2019-06-08       Impact factor: 4.791

3.  Are individuals living with mental illness and their preferred alternative decision-makers attuned and aligned in their attitudes regarding treatment decisions?

Authors:  Laura Weiss Roberts; Jane Paik Kim
Journal:  J Psychiatr Res       Date:  2016-03-15       Impact factor: 4.791

4.  Informed consent, therapeutic misconception, and clinical trials for Alzheimer's disease.

Authors:  James M Wilkins; Brent P Forester
Journal:  Int J Geriatr Psychiatry       Date:  2020-01-26       Impact factor: 3.485

5.  Negative association of perceived risk and willingness to participate in innovative psychiatric research protocols.

Authors:  Tenzin Tsungmey; Jane Paik Kim; Laura B Dunn; Katie Ryan; Kyle Lane-McKinley; Laura Weiss Roberts
Journal:  J Psychiatr Res       Date:  2019-12-18       Impact factor: 4.791

Review 6.  Determining medical decision-making capacity in brain tumor patients: why and how?

Authors:  Andrea Pace; Johan A F Koekkoek; Martin J van den Bent; Helen J Bulbeck; Jane Fleming; Robin Grant; Heidrun Golla; Roger Henriksson; Simon Kerrigan; Christine Marosi; Ingela Oberg; Stefan Oberndorfer; Kathy Oliver; H Roeline W Pasman; Emilie Le Rhun; Alasdair G Rooney; Roberta Rudà; Simone Veronese; Tobias Walbert; Michael Weller; Wolfgang Wick; Martin J B Taphoorn; Linda Dirven
Journal:  Neurooncol Pract       Date:  2020-07-16

7.  Before it is too late: professional responsibilities in late-onset Alzheimer's research and pre-symptomatic prediction.

Authors:  Silke Schicktanz; Mark Schweda; Jesse F Ballenger; Patrick J Fox; Jodi Halpern; Joel H Kramer; Guy Micco; Stephen G Post; Charis Thompson; Robert T Knight; William J Jagust
Journal:  Front Hum Neurosci       Date:  2014-11-20       Impact factor: 3.169

8.  Research involving subjects with Alzheimer's disease in Italy: the possible role of family members.

Authors:  Corinna Porteri; Carlo Petrini
Journal:  BMC Med Ethics       Date:  2015-03-04       Impact factor: 2.652

9.  The full spectrum of ethical issues in dementia research: findings of a systematic qualitative review.

Authors:  Tim G Götzelmann; Hannes Kahrass; Daniel Strech
Journal:  BMC Med Ethics       Date:  2021-03-26       Impact factor: 2.652

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.